SKINJECT Supplies Cross Linked Dermal Filler 24mg/ml to European Aesthetic Clinics and Distributors
August 25, 2026
SKINJECT (fillerha.com), the dermal filler brand of Jinan Runxin Trading Co., Ltd., is strengthening its cross linked dermal filler supply programs for aesthetic clinics and medical distributors in Germany, France, Italy, the Netherlands and Switzerland. With a manufacturing-backed base in Jinan, China, and over 90% of output exported, SKINJECT delivers cross-linked HA gels in 24 mg/ml concentrations across 2 x 1 ml and 20 ml syringe formats.
Why cross-linked HA matters in daily aesthetic practice
Cross linking stabilizes hyaluronic acid molecules so the gel resists rapid enzymatic breakdown after injection. The result is a structured, longer-lasting filler with predictable lift — the technical foundation for lip augmentation, wrinkle correction and facial contouring protocols popular in European clinics. SKINJECT's cross linked dermal filler range is built around this principle, with gel concentrations of up to 24 mg/ml for depth, projection and durability.
European portfolio highlights
| Product line | Format | Typical applications |
|---|---|---|
| Cross-linked lip & wrinkle gel (Ultra 3 / Ultra 4 type protocols) | 2 x 1 ml box | Lip volume, perioral lines, Russian lips technique |
| Cross-linked contouring gel | 2 ml / box | Nose, chin and cheek correction |
| High-density cross-linked HA | 20 ml syringe | Deep volume restoration (practitioner use) |
Regulatory-readiness for EU and Swiss buyers
European clinics and importers operate under the EU Medical Device Regulation framework, with national vigilance systems in Germany, France, Italy and the Netherlands, while Swiss partners follow Swissmedic-aligned pathways. SKINJECT supports buyers with product documentation and export dossiers to help importing entities complete their own registration and conformity steps. The company does not position itself as a substitute for local regulatory responsibility — it positions itself as a documentation-ready manufacturing partner.
Built for distributors who value consistency
- Concentration consistency: 24 mg/ml cross-linked HA gels across multiple SKUs simplify clinic training and protocol standardization.
- Format flexibility: 2 x 1 ml clinical boxes and 20 ml bulk-volume syringes cover both facial aesthetics and high-volume protocols.
- Export experience: founded in 2018 with around 100 employees, SKINJECT exports more than 90% of production worldwide, including regular European distribution programs.
- OEM/ODM programs: private-label cross linked dermal filler development for established European aesthetic brands.
Frequently asked questions
How long does a cross-linked HA filler typically last?
Duration varies by product, treatment area and individual metabolism. Cross-linked gels are designed for longer-lasting correction than non-cross-linked HA, and clinicians should follow the specific product instructions for each SKU.
Do you support distributor registration in the EU?
SKINJECT provides product documentation and export dossiers to support the importing entity's registration and conformity processes under applicable European frameworks.
Can you produce private-label cross-linked fillers?
Yes. OEM/ODM programs are available, including customized labeling and packaging configuration on selected cross-linked lines.
Learn more: explore the complete cross linked dermal filler range at www.fillerha.com or contact the SKINJECT export team for European pricing, samples and documentation.